RogerSeheultMD

Critical Care Medicine, Pleural Disease, Sleep Medicine

Physician

Dr. Seheult is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
6109 W Ramsey Street
Banning, CA 92220
Phone+1 951-845-0313

Fax+1 951-845-8194

Loma Linda University Health Education ConsortiumFellowship, Pulmonary Disease and Critical Care Medicine, 2004 - 2007
Loma Linda University Health Education ConsortiumResidency, Internal Medicine, 2000 - 2003
Loma Linda University School of MedicineClass of 2000

PubMed

An evaluation of vilobelimab (anti-C5a) as a cost-effective option to treat severely ill mechanically ventilated patients with COVID-19.
Daniel C Malone, Joseph Biskupiak, Diana Brixner, Gary Oderda, Roger Seheult
American Journal of Health-System Pharmacy. 2024-10-30
7 citations
Clinical outcomes of prolonged anticoagulation with rivaroxaban after unprovoked venous thromboembolism.
Jeffrey S. Berger, Roger Seheult, François Laliberté, Concetta Crivera, Dominique Lejeune
Research and Practice in Thrombosis and Haemostasis. 2018-01-01
6 citations
Risk for Venous Thromboembolism Recurrence Among Rivaroxaban-treated Patients Who Continued Versus Discontinued Therapy: Analyses Among Patients with VTE☆
Alok A. Khorana, Jeffrey S. Berger, Philip S. Wells, Roger Seheult, Veronica Ashton
Clinical Therapeutics. 2017-07-01

Show 1424: Breathing Better Despite Pollution, Infections, Asthma or COPDMarch 27th, 2025
How to Enhance Your Immune System | Dr. Roger SeheultFebruary 24th, 2025
ResearchDecember 19th, 2024
Join now to see all